Organization
“We strive to make prostate cancer diagnosis quicker, more affordable, and less invasive by pairing artificial intelligence technology with ultrasound imaging.”
LEADERSHIP TEAM
Mark Bloemendaal
Chief Executive Officer
Wim Zwart
Algorithm Development Lead
Armand Wemelsfelder
Product Development Lead
Mark Maris
Global Business Development Director
Anna Garrido Utrilla
Clinical Trial Manager
ADVISORY BOARD
Hessel Dijkstra
Clinical Strategic Advisor
Massimo Mischi
Scientific Strategic Advisor
Roland Zegger
Commercial Strategic Advisor
CLINICAL BOARD
Prof. Dr. Hashim Ahmed
Board Member
Prof. Dr. Chris Bangma
Board Member
Prof. Dr. Harrie Beerlage
Chairman
Prof. Dr. Alberto Briganti
Board Member
Prof. Dr. Daniel Eberli
Board Member
Prof. Dr. Jurgen Fütterer
Board Member
Prof. Dr. Peter Pinto
Board Member
Prof. Dr. Hendrick van Poppel
Board Member
Prof. Dr. Georg Salomon
Board Member
Prof. Dr. Jochen Walz
Board Member